| |
|
竹内 勤 |
慶應義塾大学医学部リウマチ・膠原病内科 教授 |
| リウマチ・膠原病学、臨床免疫学 |
| （研究論文）Kajio N, Takeshita M, Suzuki K, Kaneda Y, Yamane H, Ikeura K, Sato H, Shimizu H, Tsunoda K, and Takeuchi T. Anti-centromere antibodies target centromere-kinetochore macrocomplex: a comprehensive autoantigen profiling. Ann Rheum Dis (IF=19.103), 80:651-9, 2021.
|
（研究論文）
Choy E, de Benedetti F, Takeuchi T, Hashizume M, John MR, and Kishimoto T. Translating IL-6 biology into effective treatments. Nature Rev Rheum (IF=16.625), 16:335-45, 2020.
|
（研究論文）
Hasegawa T, Kikuta J, Sudo T, Matsuura Y, Matsui T, Simmons S, Ebina K, Hirao M, Okuzaki D, Yoshida Y, Hirao A, Kalinichenko V, Rachaudohuri P, Yamaoka K, Takeuchi T, and Ishii M. Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1. Nature Immunol (IF=20.479),20:1631-43, 2019.
|
|
| |
|
興梠博次 |
社会保険大牟田天領病院・病院長 |
| 呼吸器内科学 内科学 |
| CD8 and CD103 are highly expressed in asthmatic bronchial intraepithelial lymphocytes. Hirosako S, Goto E, Tsumori K, Fujii K, Hirata N, Ando M, Kohrogi H. Int Arch Allergy Immunol. 2010, 153:157-165
|
| T cells of atopic asthmatics preferentially infiltrate into human bronchial xenografts in SCID mice. Tsumori K, Kohrogi H, Goto E, Hirata N, Hirosako S, Fujii K, Ando M, Kawano O, Mizuta H. J Immunol 2003, 170:5712-5718
|
| Human bronchial intraepithelial T lymphocytes as a distinct T-cell subset: their long-term survival in SCID-Hu chimeras. Goto E, Kohrogi H, Hirata N, Tsumori K, Hirosako S, Hamamoto J, Fujii K, Kawano O, Ando M. Am J Respir Cell Mol Biol 2000, 22:405-411
|
|
| ○ |
|
市村恵一 |
東京みみ・はな・のどサージクリニック名誉院長 |
| 耳鼻咽喉科学 |
（総説論文）
鼻粘膜血管の構造と役割、その異常. 市村恵一.耳鼻咽喉科免疫アレルギー 2015.33(4):225-230.
|
（総説論文）
Mechanism of nasal obstruction in patients with allergic rhinitis. Ichimura K. Clin Exper Allergy Rev, 2010.10:20-27.
|
（著書）
鼻アレルギー診療ガイドライン作成委員会編：鼻アレルギー診療ガイドライン-通年性鼻炎と花粉症-．改訂第7版．市村恵一：治療 目標、治療法．Clinical Question 7 漢方薬はどういう患者に有効か。 ライフ・サイエンス. 2013. pp34-37.70.
|
|
| |
|
桑名 正隆 |
日本医科大学大学院医学研究科 大学院教授 |
| アレルギー・膠原病内科学 |
＜研究論文＞
Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM. Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med 2019; 380(26): 2518-2528.
|
＜研究論文＞
Kuwana M, Blair C, Takahashi T, Langley J, Coghlan JG. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension in the modified intention-to-treat population of the AMBITION study: a post hoc analysis. Ann Rheum Dis 2020; 79(5): 626-634
|
＜研究論文＞
Gono T, Masui K, Nishina N, Kawaguchi K, Kawakami A, Ikeda K, Kirino Y, Sugiyama Y, Tanino Y, Nunokawa T, Kaneko Y, Sato S, Asakawa K, Ukichi T, Kaieda S, Naniwa T, Okano Y, *Kuwana M, and A Multicenter Retrospective Cohort of Japanese Patients with Myositis-associated ILD (JAMI) investigators. Risk prediction modeling based on a combination of initial serum biomarkers in myositis-associated interstitial lung disease. Arthritis Rheumatol. 2021; 73(4): 677-686. doi: 10.1002/art.41566.
|
|
